{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04007276",
            "orgStudyIdInfo": {
                "id": "Lumify Study"
            },
            "organization": {
                "fullName": "Tulane University",
                "class": "OTHER"
            },
            "briefTitle": "The Effect of Lumify\u2122 on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients",
            "officialTitle": "The Effect of Lumify\u2122 (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%",
            "therapeuticArea": [
                "Other",
                "Ophthalmology"
            ],
            "study": "the-effect-of-lumify-on-ocular-redness-intraocular-pressure-and-eyelid-position-in-glaucoma-patients"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2025-11-10",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2035-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-06-26",
            "studyFirstSubmitQcDate": "2019-07-01",
            "studyFirstPostDateStruct": {
                "date": "2019-07-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Tulane University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Glaucoma represents a group of conditions that cause damage to the optic nerve and can lead to irreversible vision loss. Current treatments are aimed at lowering intraocular pressure while minimizing medication side effects. Lumify\u2122 (Brimonidine Tartrate Ophthalmic Solution 0.025%) is an FDA-approved medication for alleviating eye redness, a common side effect of glaucoma medications. The purpose of this study is to evaluate the effect of Lumify\u2122 on eye redness, intraocular pressure, and eyelid position in patients with glaucoma who are already using the Brimonidine 0.1%, 0.15% or 0.2% eye drops."
        },
        "conditionsModule": {
            "conditions": [
                "Glaucoma",
                "Glaucoma, Open-Angle",
                "Glaucoma; Drugs",
                "Droopy Eyelid",
                "Ptosis",
                "Glaucoma, Primary Open Angle"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Each patient will be randomized to receive the study medication in one eye and placebo in the other eye.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Lumify Arm",
                    "type": "EXPERIMENTAL",
                    "description": "In each subject, each eye will be randomized to receive a single drop of either Lumify\u2122 (brimonidine tartrate ophthalmic solution 0.025%) or a sterile balanced saline solution.",
                    "interventionNames": [
                        "Drug: brimonidine tartrate ophthalmic solution 0.025%"
                    ]
                },
                {
                    "label": "Control Arm",
                    "type": "SHAM_COMPARATOR",
                    "description": "In each subject, each eye will be randomized to receive a single drop of either Lumify\u2122 (brimonidine tartrate ophthalmic solution 0.025%) or a sterile balanced saline solution.",
                    "interventionNames": [
                        "Other: sterile balanced saline solution"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "brimonidine tartrate ophthalmic solution 0.025%",
                    "description": "Single dose of brimonidine tartrate ophthalmic solution 0.025% applied as an eye drop to the eye surface.",
                    "armGroupLabels": [
                        "Lumify Arm"
                    ],
                    "otherNames": [
                        "Lumify\u2122"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "sterile balanced saline solution",
                    "description": "Single dose of sterile balanced saline solution applied as an eye drop to the eye surface.",
                    "armGroupLabels": [
                        "Control Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ocular redness",
                    "description": "Scoring of ocular redness on clinical photographs using the the Investigator Ocular Redness Scale (0-4; 0 = no ocular redness, 4 = extremely severe ocular redness)",
                    "timeFrame": "5 minutes after application of eye drop"
                },
                {
                    "measure": "Ocular redness",
                    "description": "Scoring of ocular redness on clinical photographs using the the Investigator Ocular Redness Scale (0-4; 0 = no ocular redness, 4 = extremely severe ocular redness)",
                    "timeFrame": "15 minutes after application of eye drop"
                },
                {
                    "measure": "Ocular redness",
                    "description": "Scoring of ocular redness on clinical photographs using the the Investigator Ocular Redness Scale (0-4; 0 = no ocular redness, 4 = extremely severe ocular redness)",
                    "timeFrame": "30 minutes after application of eye drop"
                },
                {
                    "measure": "Ocular redness",
                    "description": "Scoring of ocular redness on clinical photographs using the the Investigator Ocular Redness Scale (0-4; 0 = no ocular redness, 4 = extremely severe ocular redness)",
                    "timeFrame": "60 minutes after application of eye drop"
                },
                {
                    "measure": "Intraocular pressure",
                    "description": "Measurement of intraocular pressure using handheld tonometer (TonoPen)",
                    "timeFrame": "60 minutes after application of eye drop"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Palpebral fissure height",
                    "description": "Measurement of distance between inner margin of upper and lower eyelids from clinical photographs",
                    "timeFrame": "60 minutes after application of eye drop"
                },
                {
                    "measure": "Eye discomfort",
                    "description": "Subjective scoring of ocular discomfort by patient on a 0-10 unit scale (0 = very comfortable, 10 = very uncomfortable)",
                    "timeFrame": "60 minutes after application of eye drop"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18 years\n* Diagnosis of primary open angle glaucoma\n* Willing and able to give informed consent\n* Current and greater than 6 weeks of brimonidine 0.2%, 0.15% or 0.1% use\n\nExclusion Criteria:\n\n* Pregnancy\n* Prisoners\n* Known allergy or sensitivities to brimonidine\n* No surgery within the past 6 months\n* No history of lid surgery or botox\n* Any other significant ophthalmologic disorder or condition with relevant effect on ocular redness, IOP, or eyelid position as evaluated by principal investigator\n* Inability to sit comfortably for 30 minutes\n* Prior use of eye whiteners (eg, vasoconstrictors), decongestants, antihistamines, or phenylephrine dilating drops within 1 week of study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ze Zhang, MD",
                    "role": "CONTACT",
                    "phone": "504-988-5831",
                    "email": "zzhang9@tulane.edu"
                },
                {
                    "name": "Whitley Richardson",
                    "role": "CONTACT",
                    "phone": "504-988-2261",
                    "email": "wrichardson@tulane.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ze Zhang, MD",
                    "affiliation": "Tulane University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Tulane University Medical Center",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ze Zhang, MD",
                            "role": "CONTACT",
                            "phone": "504-988-5831",
                            "email": "zzhang9@tulane.edu"
                        },
                        {
                            "name": "Ze Zhang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                },
                {
                    "id": "D000005902",
                    "term": "Glaucoma, Open-Angle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9014",
                    "name": "Glaucoma, Open-Angle",
                    "asFound": "Glaucoma, Open-Angle",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14261",
                    "name": "Prolapse",
                    "relevance": "LOW"
                },
                {
                    "id": "M5044",
                    "name": "Blepharoptosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M8044",
                    "name": "Erythema",
                    "relevance": "LOW"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068438",
                    "term": "Brimonidine Tartrate"
                },
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000058647",
                    "term": "Adrenergic alpha-2 Receptor Agonists"
                },
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "asFound": "Procedure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Anxiety",
                    "relevance": "HIGH"
                },
                {
                    "id": "M265",
                    "name": "Brimonidine Tartrate",
                    "asFound": "ABC",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                }
            ]
        }
    },
    "hasResults": false
}